Daniel Porat

873 total citations · 1 hit paper
22 papers, 603 citations indexed

About

Daniel Porat is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Gastroenterology. According to data from OpenAlex, Daniel Porat has authored 22 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Gastroenterology. Recurrent topics in Daniel Porat's work include Bariatric Surgery and Outcomes (10 papers), Diabetes Treatment and Management (9 papers) and Gastroesophageal reflux and treatments (6 papers). Daniel Porat is often cited by papers focused on Bariatric Surgery and Outcomes (10 papers), Diabetes Treatment and Management (9 papers) and Gastroesophageal reflux and treatments (6 papers). Daniel Porat collaborates with scholars based in Israel, Serbia and United States. Daniel Porat's co-authors include Arik Dahan, Shimon Ben‐Shabat, Ludmila Yarmolinsky, Noa Fine‐Shamir, Carmil Azran, Milica Marković, Avital Beig, Moran Zur, David Lindley and Jonathan M. Miller and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Daniel Porat

20 papers receiving 592 citations

Hit Papers

Antiviral effect of phytochemicals from medicinal plants:... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Porat Israel 11 126 105 101 96 94 22 603
Sirima Mahattanadul Thailand 11 51 0.4× 53 0.5× 189 1.9× 93 1.0× 92 1.0× 17 545
Rosângela Gonçalves Peccinini Brazil 15 32 0.3× 132 1.3× 103 1.0× 177 1.8× 44 0.5× 44 663
Valentina Buda Romania 15 36 0.3× 133 1.3× 36 0.4× 137 1.4× 44 0.5× 51 687
Sharuk L. Khan India 16 32 0.3× 37 0.4× 68 0.7× 163 1.7× 43 0.5× 45 645
Andrea Grabe‐Guimarães Brazil 16 47 0.4× 54 0.5× 39 0.4× 261 2.7× 80 0.9× 41 807
Sanjeev Kumar Sahu India 14 31 0.2× 56 0.5× 32 0.3× 197 2.1× 45 0.5× 59 646
Andréa Diniz Brazil 12 26 0.2× 82 0.8× 81 0.8× 132 1.4× 46 0.5× 38 540
Sohan S. Chitlange India 14 20 0.2× 161 1.5× 44 0.4× 89 0.9× 80 0.9× 95 686
Abeer Hanafy Egypt 14 29 0.2× 69 0.7× 311 3.1× 128 1.3× 124 1.3× 23 737
Mir Azam Khan Pakistan 13 19 0.2× 84 0.8× 73 0.7× 129 1.3× 68 0.7× 28 561

Countries citing papers authored by Daniel Porat

Since Specialization
Citations

This map shows the geographic impact of Daniel Porat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Porat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Porat more than expected).

Fields of papers citing papers by Daniel Porat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Porat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Porat. The network helps show where Daniel Porat may publish in the future.

Co-authorship network of co-authors of Daniel Porat

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Porat. A scholar is included among the top collaborators of Daniel Porat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Porat. Daniel Porat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porat, Daniel & Arik Dahan. (2025). Pharmacokinetics after bariatric surgery: adverse effects and drug safety issues in bariatric patients. Expert Review of Clinical Pharmacology. 18(3). 101–108. 1 indexed citations
2.
Azran, Carmil, et al.. (2025). Varying Lamotrigine Concentrations in Patients Following One Anastomosis Gastric Bypass Surgery: A Case Series. Journal of Pharmacy Practice. 1332810730–1332810730.
4.
Porat, Daniel, et al.. (2024). Quantification of Etoricoxib in Low Plasma Volume by UPLC-PDA and Application to Preclinical Pharmacokinetic Study. Pharmaceuticals. 17(4). 507–507. 1 indexed citations
6.
Porat, Daniel, et al.. (2023). Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokinetics. International Journal of Pharmaceutics. 645. 123347–123347. 9 indexed citations
7.
Marković, Milica, Moran Zur, Daniel Porat, et al.. (2022). The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil. Pharmaceutics. 14(7). 1360–1360. 9 indexed citations
8.
Porat, Daniel, et al.. (2022). Carbamazepine Therapy After Bariatric Surgery: Eight Sleeve Gastrectomy Cases and Review of the Literature. Obesity Surgery. 32(10). 3481–3486. 9 indexed citations
9.
Porat, Daniel, et al.. (2021). Lamotrigine therapy in patients after bariatric surgery: Potentially hampered solubility and dissolution. International Journal of Pharmaceutics. 612. 121298–121298. 10 indexed citations
10.
Porat, Daniel, et al.. (2021). Stomach pH before vs. after different bariatric surgery procedures: Clinical implications for drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 160. 152–157. 36 indexed citations
11.
Porat, Daniel, et al.. (2021). Managing the Unpredictable: Mechanistic Analysis and Clinical Recommendations for Lamotrigine Treatment after Bariatric Surgery. Journal of Clinical Medicine. 10(23). 5627–5627. 10 indexed citations
12.
Israel, Sarah, Hila Elinav, Ram Elazary, et al.. (2020). Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy. Antimicrobial Agents and Chemotherapy. 64(4). 14 indexed citations
13.
Azran, Carmil, et al.. (2019). Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects. Surgery for Obesity and Related Diseases. 15(2). 333–341. 30 indexed citations
14.
Ben‐Shabat, Shimon, Ludmila Yarmolinsky, Daniel Porat, & Arik Dahan. (2019). Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies. Drug Delivery and Translational Research. 10(2). 354–367. 253 indexed citations breakdown →
15.
Porat, Daniel, Milica Marković, Moran Zur, et al.. (2019). Increased Paracetamol Bioavailability after Sleeve Gastrectomy: A Crossover Pre- vs. Post-Operative Clinical Trial. Journal of Clinical Medicine. 8(11). 1949–1949. 23 indexed citations
16.
Dahan, Arik, et al.. (2018). Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the Literature. Obesity Surgery. 29(2). 735–738. 23 indexed citations
17.
Wolk, Omri, Milica Marković, Daniel Porat, et al.. (2018). Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability Values. Journal of Pharmaceutical Sciences. 108(1). 316–325. 15 indexed citations
18.
Lozoya-Agulló, Isabel, Moran Zur, Noa Fine‐Shamir, et al.. (2017). Investigating drug absorption from the colon: Single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion. International Journal of Pharmaceutics. 527(1-2). 135–141. 30 indexed citations
19.
Porat, Daniel & Arik Dahan. (2017). Active intestinal drug absorption and the solubility-permeability interplay. International Journal of Pharmaceutics. 537(1-2). 84–93. 62 indexed citations
20.
Beig, Avital, Noa Fine‐Shamir, Daniel Porat, et al.. (2017). Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide. European Journal of Pharmaceutics and Biopharmaceutics. 121. 97–103. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026